Yarkadas Hayati 4
Research Summary
AI-generated summary
Xylem (XYL) EVP Yarkadas Hayati Receives Stock Awards & Options ~$2.64M
What Happened
Yarkadas Hayati, EVP & President of Xylem, received multiple stock award vestings and new equity grants on March 1–2, 2026. Vested performance-based stock units delivered 4,456 (TSR), 3,679 (Adjusted EBITDA), 2,501 (Revenue) and 1,761 (ESG) shares at $128.98 each (totaling $1,599,0**;**65). An additional 2,274 shares were recorded at $0.00 (dividend reinvestment). Hayati was also granted derivative equity (8,102 shares value recorded at $128.98 = $1,044,996) representing non‑qualified stock options scheduled to vest in thirds in 2027–2029. To cover tax withholding, 565, 94 and 117 shares were withheld (disposed) for a total withholding of 776 shares ($100,089). Net change: +22,773 shares acquired − 776 withheld = +21,997 net shares.
Key Details
- Transaction dates: March 1–2, 2026. Filing date: March 3, 2026 (Form 4 accession 0001524472-26-000033). Filing appears timely.
- Prices and values recorded: vested shares at $128.98 each; total gross value of acquisitions shown ≈ $2,643,961 (does not assign value to $0 dividend-reinvested shares).
- Tax withholding (dispositions): 776 shares withheld, proceeds ≈ $100,089. These were labeled as tax-withholding disposals (code F).
- Notable footnotes: F1–F5 describe vesting of performance-based units (TSR, Adj. EBITDA, Revenue, ESG); F2 = dividend reinvestment; F6 = restricted stock units scheduled to vest in thirds; F10 = non‑qualified stock options scheduled to vest in thirds. F7–F9 explain the specific withholdings to satisfy tax liabilities.
- Shares owned after transaction: not reported in the supplied filing details.
Context
- Most of these transactions are award vestings and planned grants (code A) and routine tax-withholding (code F), not open‑market purchases or sales. Vestings and grant of options/RSUs are common executive compensation events and do not necessarily indicate a near-term buy/sell decision.
- The 8,102-share derivative entry reflects option grants (or similar) that vest over future years (one‑third increments in 2027–2029), not immediate exercised-and-sold shares.
- For retail investors: award vestings increase insider ownership but are a standard compensation mechanism; tax‑withholding dispositions are routine and reduce the net new shares received.